Design, synthesis and evaluation of N13-substituted evodiamine derivatives against human cancer cell lines

Molecules

Volumn 18, Issue 12, 2013, Pages 15750-15768

  Song, Senchuan ^a   Chen, Zhiyong ^a   Li, Shaoxue ^a   Huang, Yanmin ^b   Wan, Yiqian ^a   Song, Huacan ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b GUANGXI TEACHERS EDUCATION UNIVERSITY   (China)

Author keywords

Antitumor activity; Apoptosis; N13 substituted evodiamine derivatives; Solubility

Indexed keywords

ANTINEOPLASTIC AGENT; EVODIAMINE; QUINAZOLINE DERIVATIVE;

APOPTOSIS; ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; CONFORMATION; DRUG EFFECT; HUMAN; MCF 7 CELL LINE; SYNTHESIS; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL LINE, TUMOR; HUMANS; MCF-7 CELLS; MODELS, MOLECULAR; MOLECULAR CONFORMATION; QUINAZOLINES;

EID: 84890899778     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules181215750     Document Type: Article

References (35)

1. Yu, H.; Jin, H.; Gong, W.; Wang, Z.; Liang, H. Pharmacological actions of multi-target-directed evodiamine. Molecules 2013, 18, 1826-1843.
2. Chen, B.-Y.; Qiu, T. Traditional Chinese Medicine Composition for Treating Greasy Food Regurgitation [Machine Translation]. Patent CN 103301272 A, 18 September 2012.
3. Juchi, S.; Uchida, Y. A Hair Nourishing and Hair Growth Promoting Food Prepared from Evodia rutaecarpa benth (Evodiae fructus) or Evodia rutaecarpa benth var Officinalis Huang Belonging to Rutaceae. Patent JP 61001619, 1986.
4. Jiang, J.; Hu, C. Evodiamine: A novel anti-cancer alkaloid from evodia rutaecarpa. Molecules 2009, 14, 1852-1859.
5. Yang, J.; Cai, X.; Lu, W.; Hu, C.; Xu, X.; Yu, Q.; Cao, P. Evodiamine inhibits STAT3 signaling by inducing phosphatase shatterproof I in hepatocellular carcinoma cells. Cancer Lett. 2013, 328, 243-251.
6. Wu, J.-Y.; Chang, M.-C.; Chen, C.-S.; Lin, H.-C.; Tsai, H.-P.; Yang, C.-C.; Yang, C.-H.; Lin, C.-M. Topoisomerase I inhibitor evodiamine acts as an antibacterial agent against drug-resistant Klebsiella pneumoniae. Planta Med. 2013, 79, 27-29.
7. Wang, K.-L.; Hsia, S.-M.; Yeh, J.-Y.; Cheng, S.-C.; Wang, P.S.; Wang, S.-W. Anti-proliferative effects of evodiamine on human breast cancer cells. PLoS One 2013, 8, e67297.
8. Li-Weber, M. Targeting apoptosis pathways in cancer by Chinese medicine. Cancer Lett. 2013, 332, 304-312.
9. Wei, W.-T.; Chen, H.; Wang, Z.-H.; Ni, Z.-L.; Liu, H.-B.; Tong, H.-F.; Guo, H.-C.; Liu, D.-L.; Lin, S.-Z. Enhanced antitumor efficacy of gemcitabine by evodiamine on pancreatic cancer via regulating PI3K/Akt pathway. Int. J. Biol. Sci. 2012, 8, 1-14.
10. Wang, Z.; Sun, L.; Yu, H.; Zhang, Y.; Gong, W.; Jin, H.; Zhang, L.; Liang, H. Binding mode prediction of evodiamine within vanilloid receptor TRPV1. Int. J. Biol. Sci. 2012, 13, 8958-8969.
11. Rasul, A.; Yu, B.; Zhong, L.; Khan, M.; Yang, H.; Ma, T. Cytotoxic effect of evodiamine in SGC-7901 human gastric adenocarcinoma cells via simultaneous induction of apoptosis and autophagy. Oncol. Rep. 2012, 27, 1481-1487.
12. Pan, X.; Hartley, J.M.; Hartley, J.A.; White, K.N.; Wang, Z.; Bligh, S.W. A. Evodiamine, a dual catalytic inhibitor of type I and II topoisomerases, exhibits enhanced inhibition against camptothecin resistant cells. Phytomedicine 2012, 19, 618-624.
13. Dong, G.; Sheng, C.; Wang, S.; Miao, Z.; Yao, J.; Zhang, W. Selection of evodiamine as a novel topoisomerase I inhibitor by structure-based virtual screening and hit optimization of evodiamine derivatives as antitumor agents. J. Med. Chem. 2010, 53, 7521-7531.
14. Zhang, C.; Fan, X.; Xu, X.; Yang, X.; Wang, X.; Liang, H.-P. Evodiamine induces caspase-dependent apoptosis and S phase arrest in human colon loVo cells. Anti-Cancer Drugs 2010, 21, 766-776.
15. Wang, C.; Li, S.; Wang, M. Evodiamine-induced human melanoma A375-S2 cell death was mediated by PI3K/Akt/caspase and Fas-L/NF-κB signaling pathways and augmented by ubiquitin-proteasome inhibition. Toxicol. In Vitro 2010, 24, 898-904.
16. Dong, G.; Wang, S.; Miao, Z.; Yao, J.; Zhang, Y.; Guo, Z.; Zhang, W.; Sheng, C. New tricks for an old natural product: Discovery of highly potent evodiamine derivatives as novel antitumor agents by systemic structure-activity relationship analysis and biological evaluations. J. Med. Chem. 2012, 55, 7593-7613.
17. Chen, M.-C.; Yu, C.-H.; Wang, S.-W.; Pu, H.-F.; Kan, S.-F.; Lin, L.-C.; Chi, C.-W.; Ho, L.L.-T.; Lee, C.-H.; Wang, P.S. Anti-proliferative effects of evodiamine on human thyroid cancer cell line ARO. J. Cell. Biochem. 2010, 110, 1495-1503.
18. Yang, Z.-G.; Chen, A.Q.; Liu, B. Antiproliferation and apoptosis induced by evodiamine in human Colorectal carcinoma cells (COLO-205). Chem. Biodivers. 2009, 6, 924-933.
19. Wang, T.; Wang, Y.; Yamashita, H. Evodiamine inhibits adipogenesis via the EGFR-PKCalpha-ERK signaling pathway. FEBS Lett. 2009, 583, 3655-3659.
20. Chan, A.L.F.; Chang, W.-S.; Chen, L.-M.; Lee, C.-M.; Chen, C.-E.; Lin, C.-M.; Hwang, J.-L. Evodiamine stabilizes topoisomerase I-DNA cleavable complex to inhibit topoisomerase I activity. Molecules 2009, 14, 1342-1352.
21. Kan, S.-F.; Yu, C.-H.; Pu, H.-F.; Hsu, J.-M.; Chen, M.-J.; Wang, P.S. Anti-proliferative effects of evodiamine on human prostate cancer cell lines DU145 and PC3. J. Cell. Biochem. 2007, 101, 44-56.
22. Shyu, K.-G.; Lin, S.; Lee, C.-C.; Chen, E.; Lin, L.-C.; Wang, B.-W.; Tsai, S.-C. Evodiamine inhibits in vitro angiogenesis: Implication for antitumorgenicity. Life Sci. 2006, 78, 2234-2243.
23. Liao, C.H.; Pan, S.L.; Guh, J.H.; Chang, Y.L.; Pai, H.C.; Lin, C.H.; Teng, C.M. Antitumor mechanism of evodiamine, a constituent from Chinese herb evodiae fructus, in human multiple-drug resistant breast cancer NCI/ADR-RES cells in vitro and in vivo. Carcinogenesis 2005, 26, 968-975.
24. Shi, B.; Cao, R.; Fan, W.; Guo, L.; Ma, Q.; Chen, X.; Zhang, G.; Qiu, L.; Song, H. Design, synthesis and in vitro and in vivo antitumor activities of novel bivalent β-carbolines. Eur. J. Med. Chem. 2013, 60, 10-22.
25. Huang, Y.; Cui, J.; Zhong, Z.; Gan, C.; Zhang, W.; Song, H. Synthesis and cytotoxicity of 17a-aza-D-homo-androster-17-one derivatives. Bioorg. Med. Chem. Lett. 2011, 21, 3641-3643.
26. Chen, Z.; Cao, R.; Shi, B.; Guo, L.; Sun, J.; Ma, Q.; Fan, W.; Song, H. Synthesis and biological evaluation of 1,9-disubstituted β-carbolines as potent DNA intercalating and cytotoxic agents. Eur. J. Med. Chem. 2011, 46, 5127-5137.
27. Ma, C.; Cao, R.; Shi, B.; Zhou, X.; Ma, Q.; Sun, J.; Guo, L.; Yi, W.; Chen, Z.; Song, H. Synthesis and cytotoxic evaluation of 1-carboxamide and 1-amino side chain substituted β-carbolines. Eur. J. Med. Chem. 2010, 45, 5513-5519.
28. Chen, Z.; Cao, R.; Shi, B.; Yi, W.; Yu, L.; Song, H.; Ren, Z.; Peng, W. Synthesis of novel β-carbolines with efficient DNA-binding capacity and potent cytotoxicity. Bioorg. Med. Chem. Lett. 2010, 20, 3876-3879.
29. Huang, Y.; Cui, J.; Jia, L.; Gan, C.; Song, H.; Zeng, C.; Zhou, A. Synthesis and evaluation of some 17-acetamidoandrostane and N,N-dimethyl-7- deoxycholic amide derivatives as cytotoxic agents: Structure/activity studies. Molecules 2013, 18, 7436-7447.
30. ChemBioDraw Ultra 11.0. PerkinElmer: Waltham, MA, USA, 2013. Available online: http://www.cambridgesoft.com (accessed on 21 November 2013).
31. Simulated Gastric Fluid and Simulated Intestinal Fluid, TS. In The United States Pharmacopeia 23, the National Formulary 18; The United States Pharmacopeial Convention, Inc.: Rockville, MD, USA, 1995; p. 2053.
32. Mondal, S.K.; Mondal, N.B.; Banerjee, S.; Mazumder, U.K. Determination of drug-like properties of a novel antileishmanial compound: In vitro absorption, distribution, metabolism, and excretion studies. Indian J. Pharmacol. 2009, 41, 176-181.
33. Rawat, J.; Jain, P.K.; Ravichandran, V.; Agrawal, R.K. Synthesis and evaluation of mutual prodrugs of isoniazid, p-amino salicylic acid and ethambutol. ARKIVOC 2007, 1, 105-118.
34. Lokhande, P.; Gite, S.; Sakarkar, D.M. Dissolution method developmeng for gastro retentive controlled releave cephalaxin tablet. Int. Res. J. Pharm. 2012, 3, 244-247.
35. Ahmed, S.A.J.; Ahmed, A. HFormulation and evaluation of Piroxicam liquisolid compacts. Int. J. Pharm. Pharm. Sci. 2013, 5, 132-141.